Executive readout · one minute
Call research workspace
Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.
IBIO
$1.46
+1.75%
IBIO · iBio, Inc.
$1.46
+0.03 (+1.75%)
At close · Aug 17
Going-concern doubt
— cleared May 12, 2026
The latest filing states the doubt was alleviated.
“The history of significant losses, the negative cash flow from operations, and the dependence by the Company on its ability to obtain additional financing to fund its operations in the past raised substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed May 12, 2026
Market Cap
$71.04M
Shares
49.68M
All earnings calls
Earnings call · FY2022 Q1
iBio, Inc. Q1 FY2022 Earnings Call
iBio, Inc. Q1 FY2022 Earnings Call
Research coverage
2 live sources
Switch sources without leaving this page or losing your listening position.
Revenue
$84,000
-79.5% YoY
Diluted EPS
-$48.00
Gross margin
203.6%
+129.7 pp YoY
Net income
-$8.94M
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed Nov 15, 2021 · complete as-filed document
SEC periodic report
10-Q report
Filed Nov 15, 2021 · complete as-filed document